O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLC
- 31 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S35-35
- https://doi.org/10.1016/s0169-5002(03)91766-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: